First Time Loading...
J

Jeisys Medical Inc
KOSDAQ:287410

Watchlist Manager
Jeisys Medical Inc
KOSDAQ:287410
Watchlist
Price: 10 260 KRW -0.97% Market Closed
Updated: May 15, 2024
Section:
 

Relative Value

The Relative Value of one Jeisys Medical Inc stock under the Base Case scenario is 14 392.63 KRW. Compared to the current market price of 10 260 KRW, Jeisys Medical Inc is Undervalued by 29%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
14 392.63 KRW
Undervaluation 29%
Relative Value
Price
J
Worst Case
Base Case
Best Case

Valuation Multiples

5.8
P/S
P/S
Price to Sales
5.8
vs History
36
vs Industry
24
Median 3Y
6.1
Median 5Y
5.2
Industry
2.4
Forward
5.4
More Details
29.1
P/E
P/E
Price to Earnings
29.1
vs History
47
vs Industry
21
Median 3Y
24.1
Median 5Y
29.5
Industry
23.9
Forward
28.1
More Details
23.2
P/OCF
P/OCF
Price to OCF
23.2
vs History
77
vs Industry
19
Median 3Y
26.2
Median 5Y
30.3
Industry
15.6
More Details
28.3
P/FCFE
P/FCFE
Price to FCFE
28.3
vs History
85
vs Industry
20
Median 3Y
37.7
Median 5Y
52
Industry
22.5
More Details
9.2
P/B
P/B
Price to Book Value
9.2
vs History
31
vs Industry
7
Median 3Y
9.6
Median 5Y
8
Industry
2.3
More Details
5.5
EV/S
EV/S
Enterprise Value to Sales
5.5
vs History
36
vs Industry
22
Median 3Y
5.8
Median 5Y
5
Industry
2.5
Forward
5.1
More Details
8
EV/GP
EV/GP
Enterprise Value to Gross Profit
8
vs History
36
vs Industry
29
Median 3Y
8.4
Median 5Y
7.3
Industry
5.3
More Details
18.4
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
18.4
vs History
31
vs Industry
20
Median 3Y
18.9
Median 5Y
15.7
Industry
12.9
Forward
17.5
More Details
20.5
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
20.5
vs History
30
vs Industry
24
Median 3Y
20.9
Median 5Y
17.1
Industry
17.8
Forward
19.4
More Details
22.1
EV/OCF
EV/OCF
Enterprise Value to OCF
22.1
vs History
57
vs Industry
20
Median 3Y
25.2
Median 5Y
23.1
Industry
15.4
More Details
25
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
25
vs History
63
vs Industry
20
Median 3Y
35.9
Median 5Y
32.5
Industry
19.6
More Details
10.4
EV/IC
EV/IC
Enterprise Value to IC
10.4
vs History
65
vs Industry
8
Median 3Y
10.9
Median 5Y
11.9
Industry
2
More Details

Multiples Across Competitors

Competitors Multiples
Jeisys Medical Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
KR
Jeisys Medical Inc
KOSDAQ:287410
779.9B KRW 5.8 29.1 18.4 20.5
US
Abbott Laboratories
NYSE:ABT
181.9B USD 4.5 32.3 19.1 28.5
US
Intuitive Surgical Inc
NASDAQ:ISRG
141.2B USD 19.3 71.1 58.4 73.2
US
Stryker Corp
NYSE:SYK
126.1B USD 6 37.5 24.4 30
IE
Medtronic PLC
NYSE:MDT
112B USD 3.5 26.7 14.1 20
US
Boston Scientific Corp
NYSE:BSX
109.1B USD 7.4 61.9 31 45.9
US
Becton Dickinson and Co
NYSE:BDX
68.5B USD 3.5 56.1 18.8 39.7
DE
Siemens Healthineers AG
XETRA:SHL
59.7B EUR 2.7 39.3 18.8 31.7
US
Edwards Lifesciences Corp
NYSE:EW
54B USD 8.8 38.3 27.8 30.1
CN
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
376.2B CNY 10.5 30.9 28.4 28.4
US
Dexcom Inc
NASDAQ:DXCM
51.4B USD 13.5 80.5 60.1 78.2

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 137,600+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.